Xencor, Inc Amortization of Intangible Assets
Xencor, Inc (XNCR) reported Amortization of Intangible Assets of $200.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-05
- Xencor, Inc amortization of intangible assets for the quarter ending 2026-06-30 was $200.00K, a 33.33% decline year-over-year.
- Xencor, Inc amortization of intangible assets for the quarter ending 2026-03-31 was $200.00K, a 33.33% decline year-over-year.
- Xencor, Inc amortization of intangible assets for the quarter ending 2025-12-31 was $200.00K, a 33.33% decline year-over-year.
- Xencor, Inc amortization of intangible assets for the quarter ending 2025-09-30 was $200.00K, a 33.33% decline year-over-year.
- Xencor, Inc amortization of intangible assets for fiscal 2025 was $900.00K, a 30.77% decline from fiscal 2024.
- Xencor, Inc amortization of intangible assets for fiscal 2024 was $1.30M, a 0.00% change from fiscal 2023.
- Xencor, Inc amortization of intangible assets for fiscal 2023 was $1.30M, a 7.14% decline from fiscal 2022.
- Xencor, Inc amortization of intangible assets for fiscal 2022 was $1.40M, a 16.67% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $200.00K 10-Q · filed 2026-08-05 | $400.00K 10-Q · filed 2026-08-05 | $600.00K derived: sum of 3 quarters · filed 2026-08-05 | $800.00K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $200.00K 10-Q · filed 2026-05-06 | $400.00K derived: sum of 2 quarters · filed 2026-05-06 | $600.00K derived: sum of 3 quarters · filed 2026-05-06 | $900.00K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $400.00K derived: sum of 2 quarters · filed 2026-02-25 | $700.00K derived: sum of 3 quarters · filed 2026-08-05 | $900.00K 10-K · filed 2026-02-25 | |
| 2025-09-30 | $200.00K 10-Q · filed 2025-11-05 | $500.00K derived: sum of 2 quarters · filed 2026-08-05 | $700.00K 10-Q · filed 2025-11-05 | $1.10M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $300.00K 10-Q · filed 2026-08-05 | $500.00K 10-Q · filed 2026-08-05 | $900.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.20M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $300.00K 10-Q · filed 2026-05-06 | $600.00K derived: sum of 2 quarters · filed 2026-05-06 | $900.00K derived: sum of 3 quarters · filed 2026-05-06 | $1.20M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $600.00K derived: sum of 2 quarters · filed 2026-02-25 | $900.00K derived: sum of 3 quarters · filed 2026-02-25 | $1.30M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $300.00K 10-Q · filed 2025-11-05 | $600.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.00M 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | $300.00K 10-Q · filed 2025-08-06 | $600.00K 10-Q · filed 2025-08-06 | |||
| 2024-03-31 | $300.00K 10-Q · filed 2025-05-07 | ||||
| 2023-12-31 | $1.30M 10-K · filed 2026-02-25 | ||||
| 2022-12-31 | $1.40M 10-K · filed 2025-02-27 | ||||
| 2021-12-31 | $1.20M 10-K/A · filed 2025-02-24 | ||||
| 2020-12-31 | $1.10M 10-K · filed 2023-02-27 | ||||
| 2019-12-31 | $900.00K 10-K · filed 2022-02-24 | ||||
| 2018-12-31 | $900.00K 10-K · filed 2021-02-24 | ||||
| 2017-12-31 | $800.00K 10-K · filed 2020-02-25 | $784.00K 10-K · filed 2018-02-28 | |||
| 2016-12-31 | $800.00K 10-K · filed 2019-02-26 | $755.00K 10-K · filed 2017-03-01 | |||
| 2015-12-31 | $594.00K 10-K · filed 2018-02-28 | ||||
| 2014-12-31 | $694.00K 10-K · filed 2017-03-01 | ||||
| 2013-12-31 | $598.00K 10-K · filed 2016-03-08 | ||||
| 2012-12-31 | $373.00K 10-K · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |